Literature DB >> 19329881

The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum.

Sander ten Raa1, Helma M U van Grevenstein, Miranda ten Kate, Kristin M Mangundap, Leo J Hofland, Hans Jeekel, Wim Sluiter, Casper H J van Eijck.   

Abstract

Postoperative peritoneal carcinomatosis is a significant clinical problem after "curative" resection of pancreatic carcinoma. Preoperative surgical trauma activates a cascade of peritoneal defense mechanisms responsible for postoperative intra-abdominal tumor recurrence. Reactive oxygen species (ROS) play a pivotal role in this postoperative inflammatory reaction. This study explores the influence of ROS on adhesion of human pancreatic carcinoma cells to human mesothelial cells. Furthermore this study explores the influence of ROS on the presentation of adhesion molecules on Panc-1 and mesothelial cells. ROS were produced using the enzymatic reaction of xanthine with xanthine oxidase (X/XO). A reproducible in vitro assay to study adhesion of human Panc-1 carcinoma tumor cells to a mesothelial cell monolayer of primary human mesothelial cells was used. Mesothelial monolayers were incubated with ROS produced prior to adhesion of the tumor cells. Incubation of the mesothelial cells with X/XO resulted in a significant increase (69.5%) in adhesion of Panc-1 in all patients. SOD/catalase, anti-oxidants, could reduce this increase by 56.7%. ROS significantly influenced the expression of the adhesion molecules ICAM-1, VCAM-1 and CD44h on mesothelial cells, but did not influence adhesion molecule expression on Panc-1. The ROS released during the post-operative inflammatory reaction may play an important role in the adhesion of pancreatic tumor cells to the mesothelium-possibly by influencing adhesion molecule expression on mesothelial cells. Therefore ROS can partly be responsible for the enhanced post-operative intra-abdominal tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19329881      PMCID: PMC2633975          DOI: 10.4161/cam.1.2.4283

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  26 in total

Review 1.  AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association.

Authors:  E P DiMagno; H A Reber; M A Tempero
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

2.  Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence.

Authors:  M E van Rossen; W Sluiter; F Bonthuis; H Jeekel; R L Marquet; C H van Eijck
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

3.  Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum.

Authors:  M E van Rossen; L J Hofland; M P van den Tol; P M van Koetsveld; J Jeekel; R L Marquet; C H van Eijck
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

4.  The role of oxygen free radicals in human disease processes.

Authors:  G B Bulkley
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

5.  Influence of proinflammatory cytokines on the adhesion of human colon carcinoma cells to lung microvascular endothelium.

Authors:  Miranda ten Kate; Leo J Hofland; Wilhelmina M U van Grevenstein; Peter V van Koetsveld; Johannes Jeekel; Casper H J van Eijck
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

6.  Tumour-expressed CD43 (sialophorin) mediates tumourmesothelial cell adhesion.

Authors:  Paul Ziprin; Nawar A Alkhamesi; Paul F Ridgway; David H Peck; Ara W Darzi
Journal:  Biol Chem       Date:  2004-08       Impact factor: 3.915

7.  ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases.

Authors:  Paul Ziprin; Paul F Ridgway; Katherine L M Pfistermüller; David H Peck; Ara W Darzi
Journal:  Cell Commun Adhes       Date:  2003 May-Jun

8.  Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.

Authors:  Ingrid M Meszoely; John S Lee; James C Watson; Michael Meyers; Hao Wang; John P Hoffman
Journal:  Am Surg       Date:  2004-03       Impact factor: 0.688

9.  Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells.

Authors:  Eva C Vaquero; Mouad Edderkaoui; Stephen J Pandol; Ilya Gukovsky; Anna S Gukovskaya
Journal:  J Biol Chem       Date:  2004-05-23       Impact factor: 5.157

10.  Enhancement of integrins by interleukin-1alpha, and their relationship with metastatic and invasive behavior of human pancreatic ductal adenocarcinoma cells.

Authors:  Hirozumi Sawai; Hiromitsu Takeyama; Minoru Yamamoto; Akiyoshi Furuta; Hitoshi Funahashi; Yuji Okada; Mikinori Sato; Moritsugu Tanaka; Tadao Manabe
Journal:  J Surg Oncol       Date:  2003-01       Impact factor: 3.454

View more
  4 in total

Review 1.  The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2017-09-27       Impact factor: 9.261

Review 2.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150

3.  Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.

Authors:  Justyna Mikuła-Pietrasik; Patrycja Sosińska; Konstantin Maksin; Mał Gorzata Kucińska; Hanna Piotrowska; Marek Murias; Aldona Woźniak; Dariusz Szpurek; Krzysztof Książek
Journal:  Oncotarget       Date:  2015-10-06

Review 4.  Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.

Authors:  Lun Zhang; Jiahui Li; Liang Zong; Xin Chen; Ke Chen; Zhengdong Jiang; Ligang Nan; Xuqi Li; Wei Li; Tao Shan; Qingyong Ma; Zhenhua Ma
Journal:  Oxid Med Cell Longev       Date:  2016-01-03       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.